A robust R&D project portfolio optimization model for pharmaceutical contract research organizations
Year of publication: |
2014
|
---|---|
Authors: | Hassanzadeh, Farhad ; Modarres, Mohammad ; Nemati, Hamid R. ; Amoako-Gyampah, Kwasi |
Published in: |
International journal of production economics. - Amsterdam [u.a.] : Elsevier, ISSN 0925-5273, ZDB-ID 1092526-0. - Vol. 158.2014, p. 18-27
|
Subject: | Pharmaceutical contract research organization (CRO) | Research and Development (R&D) | Project selection and scheduling | Uncertainty | Robust optimization | Arzneimittel | Pharmaceuticals | Industrieforschung | Industrial research | Pharmakologie | Pharmacology | Pharmaindustrie | Pharmaceutical industry | Theorie | Theory | Portfolio-Management | Portfolio selection | Projektmanagement | Project management | Forschung | Research | Robustes Verfahren | Robust statistics | Produktentwicklung | New product development |
-
Rival signals and project selection : insights from the drug development process
Markou, Panos, (2023)
-
Private versus social incentives for pharmaceutical innovation
González, Paula, (2015)
-
Accelerating vaccine innovation for emerging infectious diseases via parallel discovery
Barberio, Joseph, (2023)
- More ...
-
A robust R&D project portfolio optimization model for pharmaceutical contract research organizations
Hassanzadeh, Farhad, (2014)
-
Hassanzadeh, Farhad, (2014)
-
A robust optimization approach to R&D portfolio selection
Hassanzadeh, Farhad, (2009)
- More ...